GOSS - Gossamer Bio to launch ~$212M private placement of securities

2023-07-20 08:33:09 ET

• Biopharmaceutical company Gossamer Bio ( NASDAQ: GOSS ) said on Thursday that it is set to offer securities in an ~$212M private placement.
• The company has entered into a securities purchase agreement with institutional and accredited investors.
• Gossamer is selling 129.9M shares, and accompanying warrants to purchase up to 32.5M shares, at $1.63125 per share, and accompanying warrant at $1.85125 per share.
• The warrants will have an exercise price of $2.04 per share.
• The private placement is expected to close on July 24.
• The financing was priced at-the-market under Nasdaq rules.
• The net proceeds are intended to be used to fund the ongoing development and commercialization of seralutinib and for working capital and general corporate purposes.
• GOSS shares were trading -15.93% pre-market.
• Source: Press Release

For further details see: